Abstract
Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. For each country you will receive 4 completely updated reports sent quarterly, plus comprehensive report sent annually.
These reports analyse the issues
The Outlook for Pharmaceutical Markets in Asia is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, plus comprehensive report sent annually. There are over 65 markets covered in the worldwide series.
4 Key Markets Covered!
- Bangladesh
- China
- India
- Pakistan
FOR EVERY MARKET,SENT QUARTERLY
MARKET OUTLOOK
- Current market size
- Unique 5-Year market projections to 2011
- Market outlook
- Comment & rating, covering 8 key areas such as use of generic drugs, intellectual property, pricing and the health systems
- Market structure
- Statistical data on imports and exports
- Market developments, covering recent and impending developments with respect to key issues such as regulation, health facilities, funding and government policy
- Key national data projections
FOR EVERY MARKET, SENT ANNUALLY
BACKGROUND DATA
- Population data, including growth trends and age structure
- Demographic indicators detailing principal causes of death and morbidity
HEALTHCARE SYSTEM
- Organisation & administration
- Health expenditure
- Expenditure by source of funding and type
- Hospital services
- Hospital data such as beds by type, region, specialty, patient admissions and surgical procedures
- Outpatient care
- Medical personnel
- Data on healthcare professionals covering such areas as doctors by specialty, nursing staff and dentists
ACCESSING THE PHARMA MARKET
- Regulatory environment
- Distribution guide and trade fair information
- Domestic production
CONTACT DETAILS
For healthcare organisations and trade associations
Table of Contents
BANGLADESH BACKGROUND DATA
- GEOGRAPHY
- POLITICAL OVERVIEW
- ECONOMIC OVERVIEW
- GDP, 1996-2012
- POPULATION
- Population Forecasts by Source, 2000-2006 (millions)
- DEMOGRAPHIC INDICATORS
- Principal Demographic Indicators, 1994-2004
- MORTALITY
- MORBIDITY
- Estimated Prevalence of Selected Illnesses, 1997
- Reported Communicable Diseases, 1995-1998
- HIV/AIDS
- Tuberculosis
- CHARTS
- Population by Age Group, 2004 (%)
BANGLADESH HEALTHCARE SYSTEM
- ORGANISATION & ADMINISTRATION
- HEALTH EXPENDITURE
- Budgeted Government Health Expenditure, 1997/98-2000/01 (Tk millions)
- Public Health Expenditure by Type, 1993/94-1996/97 (Tk millions)
- HOSPITAL SERVICES
- Hospitals by Type, 1996-2000
- Hospitals by Region (Division), 1996/97
- Beds by Type, 1996-2000
- Public Beds by Region (Division), 1996/7
- Hospital Beds, 1992-2000
- Private Hospitals by District, 1996/97
- AMBULATORY CARE
- Public Primary Care Facilities, 1994-2004
- MEDICAL PERSONNEL
- Medical Personnel, 1992-2004
- CHARTS
- Public Health Expenditure 1988/89-2000/01 (Tk millions)
BANGLADESH ACCESSING THE PHARMACEUTICAL MARKET
- INTRODUCTION
- REGULATORY ENVIRONMENT
- National Drug Policy
- Traditional Medicine
- Patent Protection & Intellectual Property Rights
- DISTRIBUTION CHANNELS
- Distributors
- TRADE FAIRS
- Asia Pharma Expo 2007
- DOMESTIC PRODUCTION
- Domestic Pharmaceutical Production, 1989-1999
- Licensed Pharmaceutical Businesses by Categories, 1996-2000
- Beximco
- Novartis (Bangladesh) Limited
- BAPI Members, 2007
- DIRECTORY
- Organisations
- Trade Associations
- CHARTS
- Domestic Pharmaceutical Production, 1989-1999 (US$ millions)
CHINA BACKGROUND DATA
- Geographic
- Political
- Economic
- Population
- Population Estimates, 1991-2003
- Population by Province, December 2003
- Population Growth
- Demographic Indicators
- Principal Demographic Indicators, 1998-2003
- Demographic Indicators by Province, 2003
- Mortality
- Major Causes of Death, 1999
- Major Causes of Death in Urban Areas, 1999-2002
- Major Causes of Death in Rural Areas, 1999-2002
- Morbidity
- Reported Infectious Diseases, 1998-2002 (Rate per 100,000 population)
- Chronic Diseases
- HIV/AIDS
- Tuberculosis
- Tobacco
- Reported Infectious Diseases, 1998-2002 (Rate per 100,000 population)
CHINA HEALTHCARE SYSTEM
- ORGANISATION & ADMINISTRATION
- Ministry of Health
- Hospitals
- Rural Healthcare
- Health Insurance
- Rural Co-operative Medical Care System
- Commercial Medical Insurance
- Red Cross Society of China
- HEALTH EXPENDITURE
- Total Health Expenditure, 1995-2002 (Yuan billions)
- HOSPITAL SERVICES
- Healthcare Facilities
- Healthcare Institutions by Type, 2000-2003
- Hospitals by Type, 1998
- Healthcare Institutions by Type, 2002
- Healthcare Institutions by Type and Province, 2002
- Joint venture hospitals
- Hospital Beds
- Healthcare Beds, 1995-2003 (000s)
- Number of Beds in Healthcare Institutions by Type, 2000-2002
- Beds by Region, 2003
- Hospital Beds by Department, 2000 and 2002 (000s)
- Military Hospitals
- Private Hospitals
- Hospital Activity
- Hospital Admissions, 1999-2003 (millions)
- Hospital Bed Utilisation Statistics, 1992-2001
- Bed Occupancy Rates by Type of Hospital, 1992-2001 (%)
- Bed Turnover & Days in Use by Type of Hospital, 1992-2001
- AMBULATORY CARE
- Outpatient Facilities, 2000-2003
- Hospital Outpatient Activity
- Hospital Outpatient Visits, 1999-2001 (millions)
- Outpatient Facilities, 2000-2003
- MEDICAL PERSONNEL (22-39)
- Medical Personnel (000s), 2000-2003
- Middle and High Level Health Professionals, 1995-2001
- Medical Personnel by Province, 2003
- Medical Technical Personnel by Type of Institution, 1998 (000s)
- Number of Doctors by Department, 2000
- Rural Physician Reforms
CHINA ACCESSING THE PHARMACEUTICAL MARKET
- INTRODUCTION
- REGULATORY ENVIRONMENT
- Pharmaceutical Registration
- State Food and Drug Administration (SFDA)
- Department of Drug Registration
- Department of Drug Safety & Inspection
- Department of Drug Market Compliance
- Drug Classification
- Biotech regulation
- New Regulatory Legislation
- 2001 DAL Amendments
- The Drug Import Regulation
- GMP Regulations
- Pharmaceutical Registration/Drug Approval Process
- Clinical trials
- Quality test
- Certification
- Packaging Regulations
- Post-market Surveillance
- Sector Development
- Pharmaceutical Advertising
- Sector Development
- Patent Protection & Intellectual Property Rights
- Administrative Protection
- Pharmaceutical Pricing and Reimbursement
- Pricing
- Pricing Sector Development
- Provincial governments
- Reimbursement Lists
- DISTRIBUTION CHANNELS
- Distribution System Reform
- Internet Pharmaceutical Distribution
- Pharmaceutical retail
- Distributors
- Chindex
- Hainan Kangtong Pharmaceutical Co Ltd.
- Hunan Provincial Medicines & Health Products Import & Export Corp.
- Shandong Medicines & Health Products Import & Export Corp.
- Sincer Pharmchem Ltd
- Sinochem Jiangsu Suzhou Import Export Corp
- Tianjin Medicines & Health Products Import & Export Corp
- PHARMACEUTICAL IMPORTS
- Summary Pharmaceutical Imports, 1999-2003 (US$000s)
- Leading Suppliers of Raw Materials, 2003 (US$000s)
- Leading Suppliers of Medicaments, 2003 (US$000s)
- Imports of Pharmaceuticals, 1999-2003 (US$000s)
- Leading Suppliers, 2003 (U$000s)
- Leading Suppliers by Category, 2003 (US$000s)
- DOMESTIC PRODUCTION
- Chinese Medical/Pharmaceutical Production, 2001-02
- 10th Five Year Plan Targets
- Zhejiang pharmaceutical investment plans
- HIV/AIDS drugs
- Chinese Medical/Pharmaceutical Production, 2001-02
- Domestic Producers
- Anhui Anke Biotech
- Beijing Four Ring Pharmaceutical Factory
- Changzhou Siyao Pharmaceuticals Co. Ltd
- China Pharmaceutical Enterprise
- Dragon Pharmaceuticals
- Dragon Pharmaceutical revenues, 2003-04 (US$ millions)
- Dragon Pharmaceutical revenues by Segment, Q1 2005 (US$ millions)
- Fuzhou Antibiotic Group Corp
- Haizhou Pharmaceutical Co. Ltd
- Heshuo Ephedrine Factory
- Huazhong Pharmaceutical Co. Ltd
- Jiangsu Jiangan Pharmaceutical Corp Ltd
- Jiuyuan
- Livzon (Group) Libao Biochemical & Pharmaceutical Co Ltd
- Ningbo Jierfu Pharmaceutical Co Ltd
- North China Pharmaceutical Huasheng Co. Ltd
- Shandong Xinhua Lukang Pharmaceutical Group
- Shenyang Sunshine Pharmaceutical Co Ltd
- Shenzhen Kexing Biotech
- Shenzhen Pharmaceutical Factory
- Shenzhen Taitai Pharmaceutical Industry (Taitai)
- Wenzhou Pharmaceutical Factory
- Xiamen No.2 Pharmaceutical Factory
- Xi' an Pharmaceutical Factory
- Yiyuan Pharmaceutical Co Ltd
- Zhejiang Jinhua Lixin Fine Chemicals Co Ltd
- Multinational Producers
- Allergan
- Antibioticos
- AstraZeneca
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Pharmaceutical Co. (China)
- Eli Lilly
- GlaxoSmithKline
- Johnson & Johnson
- Laboratories Servier
- Merck KGaA
- Merck Sharp & Dohme
- Novartis
- Novo Nordisk
- Pfizer
- Ranbaxy
- Rexim SA (Degussa)
- Roche
- Sankyo
- Sanofi-Synthèlabo
- Schering-Plough
- Takeda
- Tanabe
- Valeant Pharmaceuticals
- Watson
- Yamanouchi
- Research & Development
- SFDA initiatives
- Zhangjiang Hi-Tech Park
- Beijing Union Pharmaceutical Factory
- AstraZeneca
- Exports
- Summary Pharmaceutical Exports, 1999-2003 (US$000s)
- Exports of Pharmaceuticals 1999-2003
- Leading Destinations, 2003 (U$000s)
- Pharmaceutical Balance of Trade, 1999-2003
- DIRECTORY
- CHARTS
- Imports of Raw Materials/Retail Medicaments, 1998-2003 (US$000s)
- Leading Suppliers, 2003 (%)
- Exports by Category, 2003 (%)
- Leading Destinations, 2003 (%)
INDIA BACKGROUND DATA
- GEOGRAPHY
- POLITICAL OVERVIEW
- ECONOMIC OVERVIEW
- POPULATION
- Population by States and Territories, 2001-2006
- DEMOGRAPHIC INDICATORS
- Demographic Indicators, 1995-2005
- Demographic Indicators by State, 2005
- MORTALITY
- Major Causes of Death, Rural India 1993-1998
- Deaths from Non-Communicable Diseases, 1998
- MORBIDITY
- National Rural Health Mission
- Child Survival and Safe Motherhood
- Reproductive and Child Health Programme
- Woman & Child Development Project
- Universal Immunisation Programme
- Reported Incidence of Vaccine Preventable Diseases, 1985-2000
- Reducing Fertility
- Family Planning
- All India Hospitals Post-Partum Programme
- Universal Immunisation Programme
- National Health Programmes for Disease Control/Eradication
- National Vector Borne Disease Control Programme
- Malaria
- Reported Malaria Incidence & Deaths, 1990-2004
- Filariasis
- Kala-azar
- Reported Kala-azar Cases & Deaths, 1996-2004
- Japanese Encephalitis
- Suspected Japanese Encephalitis Cases & Deaths, 2000-2005
- Malaria
- National Programme for the Control of Blindness
- National Leprosy Eradication Programme
- National Tuberculosis Control Programme
- HIV/AIDS
- National AIDS Control Programme
- Cancer
- National Vector Borne Disease Control Programme
- CHARTS
- Map of India
- Population by Age Group, 2006 (%)
INDIA HEALTHCARE SYSTEM
- ORGANISATION & ADMINISTRATION
- The Department of Health
- The Department of Family Welfare
- The Department of Indian Systems of Medicine & Homeopathy
- Health Insurance
- Apollo Family Health Plan
- HEALTH EXPENDITURE
- Health Expenditure by Source of Funds, 2001/02
- Department of Health Budget Allocations, 2004-2006
- MoHFW Health Expenditure by Scheme, 2004/05
- HOSPITAL SERVICES
- Hospital Resources
- Hospitals & Beds by State & Sector, 2002
- Government Hospitals/CHCs and Beds by State, 2006
- Hospitals, Dispensaries & Beds, 1991-1998
- Beds in Selected Hospitals, 2001/02
- All India Institute of Medical Sciences (AIIMS)
- AIIMS Hospital Beds, 1999/2000
- AIIMS Hospital Beds by Specialty, 1999/2000
- AIIMS Hospital Activity, 1999/2000
- Safdarjung Hospital, New Delhi
- Safdarjung Hospital Beds by Specialty, 2003
- Dr. Ram Manohar Lohia Hospital, New Delhi
- Dr. Ram Manohar Lohia Hospital Beds by Specialty, 2000/01
- JIPMER Hospital, Pondicherry
- JIPMER Hospital Beds by Specialty, 2000
- PGIMER Nehru Hospital, Chandigarh
- PGIMER Nehru Hospital Beds by Specialty, 2001/02
- Lady Hardinge Medical College Associated Hospitals, New Delhi
- Private Hospitals and Clinics
- Apollo Hospitals Group
- Fortis Healthcare
- Max Healthcare
- Other Commercial Providers
- AMBULATORY CARE
- Sub-centres and Primary Health Centres, 2004-2005 (September)
- CGHS Out-patient Facilities, 31st March 2005
- First Aid and Disaster Relief
- St. John Ambulance
- Indian Red Cross Society
- Healthcare for the Underprivileged, Scheduled Castes and Scheduled Tribes
- Healthcare Infrastructure in Tribal/Scheduled Caste Areas, 1995-2005
- Medical Care for Remote & Marginalised Tribal & Nomadic Communities
- MEDICAL PERSONNEL
- Doctors Registered with State Medical Councils, 1995-2004
- Registered Dental Surgeons, 1994-2004
- Registered Nursing Personnel, 1994-2004
- Healthcare Personnel in Rural Areas, 1998-2005
- CHARTS
- Health Expenditure by Source, 2001/02 (%)
- Department of Health Budget Allocation by Segment, 2005/06 (%)
INDIA ACCESSING THE PHARMACEUTICAL MARKET
- INTRODUCTION
- REGULATORY ENVIRONMENT
- National Pharmaceuticals Policy 2006
- Pharmaceutical Registration
- Advertising
- Patent Protection & Intellectual Property Rights
- Background to Pharmaceutical Patents
- Mashelkar Committee Report, December 2006
- The Patents (Amendments) Bill, 2005
- Compulsory Licensing
- Pre- & Post-Grant Opposition
- Mailbox Applications
- Other Issues
- The Patents (Amendment) Rules 2006
- Previous Patents Act Amendments and Exclusive Marketing Rights
- Glivec/Gleevec Patent Setback for Novartis
- Pricing
- Drugs (Prices Control) Amendment Order and Second Amendment Order, 2006
- Price Reductions
- Drug Price Control Review Committee
- DISTRIBUTION CHANNELS
- Medical Stores Organisation
- TRADE FAIRS
- Pharma + Biotech World Expo 2007
- India Pharma 2006
- DOMESTIC PRODUCTION
- Global Sales by Leading Domestic Companies, 2005/06
- BCG Vaccine Laboratory, Chennai (Madras)
- Trade Associations
- Domestic Producers
- Alembic Ltd
- Alembic Financial Results, 2003-2006
- Aurobindo Pharma
- Aurobindo Pharma' s ANDA Approvals, 2004-2007
- Aurobindo Pharma Financial Results, 2003-2006
- Biocon
- Biocon Financial Results, 2003-2006
- Blue Cross Laboratories Ltd
- Cipla Ltd
- Cipla Financial Results, 2003-2006
- Dr. Reddy' s Laboratories Ltd
- Dr Reddy' s Laboratories ANDA approvals, 2002-2006
- Dr Reddy' s Financial Summary, 2003-2006
- Lupin Limited
- Lupin' s ANDA approvals, 2003-2006
- Lupin Financial Results, 2003-2006
- Natco Pharma
- Natco Pharma Financial Results, 2003-2006
- Nicholas Piramal India Ltd
- NPIL Financial Results, 2003-2006
- Orchid Chemicals & Pharmaceuticals Ltd
- Orchid' s Top-10 Brands
- Orchid' s ANDA Approvals, 2005-2006
- Orchid Financial Results, 2003-2006
- Ranbaxy Laboratories Ltd
- Ranbaxy' s Top 10 Molecules (US$ Million)
- Ranbaxy Laboratories ANDA approvals 2002-2006
- Ranbaxy Financial Results, 2003-2006
- Sun Pharmaceutical Industries Ltd
- Sun Pharma ANDA Approvals, 2006-2007
- Caraco Pharmaceutical ANDA Approvals, 2002-2006
- Sun Pharma Financial Results, 2003-2006
- Wockhardt Ltd
- Wockhardt' s ANDA Approvals, 2003-2006
- Wockhardt Financial Results, 2003-2005
- Zydus Cadila
- Zydus' ANDA Approvals, 2005-2007
- Zydus Cadila Financial Results, 2003-2006
- Domestic Formulation Sales by Therapy Area, 2006
- Multinational Activity
- Actavis
- GlaxoSmithKline
- Pfizer India
- sanofi-aventis
- Alembic Ltd
- Research & Development
- New Millennium Indian Technology Leadership Initiative
- Indian Council of Medical Research
- Central Research Institute, Kasauli
- Central Drug Research Institute, Lucknow
- Central Council for Research in Unani Medicine
- Central Council for Research in Ayurveda and Siddha
- Central Council for Research in Homeopathy
- Traditional Indian Medicines
- Components
- Ayurvedic Supply
- DIRECTORY
- Government Organisations
- Trade Associations
- CHARTS
- Cipla Exports by Geographic Area, 2006 (%)
- Dr Reddy' s Sales by Geographic Area, 2006 (%)
- Orchid API Sales by Region, 2006 (%)
- Orchid Formulations Sales by Region, 2006 (%)
- Wockhardt Sales by Region, 2005 (%)
PAKISTAN BACKGROUND DATA
- GEOGRAPHY
- Map of Pakistan
- POLITICAL OVERVIEW
- ECONOMIC OVERVIEW
- POPULATION
- Population by Region, 2003
- DEMOGRAPHIC INDICATORS
- Principal Demographic Indicators, 2001-2003
- MORTALITY
- Causes of Death, 2001
- MORBIDITY
- HIV/AIDS
- HIV/AIDS prevention project
- CHARTS
- Population by Age Group, 2003 (%)
- Causes of Death, 2001 (%)
PAKISTAN HEALTHCARE SYSTEM
- ORGANISATION & ADMINISTRATION
- HEALTH EXPENDITURE
- Federal Government Health Expenditure, 1993/94 - 2002/03
- HOSPITAL SERVICES
- Total Healthcare Facilities, 2005
- Hospitals by Province, 1998-2005
- Total Beds by Province, 1998-2005
- Hospital Beds, 1995-2005
- AMBULATORY CARE
- Primary Health Facilities & Beds, 1998-2005
- Dispensaries & MCH Facilities by Province, 2005
- MEDICAL PERSONNEL
- Medical Personnel, 1997-2004
- Dentists by Gender and Year of Registration, 1995-2005
PAKISTAN ACCESSING THE PHARMACEUTICAL MARKET
- INTRODUCTION
- REGULATORY ENVIRONMENT
- Pharmaceutical Registration
- Registered Drugs under the 1976 Drugs Act
- Registration Fees
- Registration Fees (Rs)
- Registered Drugs under the 1976 Drugs Act
- Licensing
- Retail Licences
- Manufacturing Licences
- Labelling & Packaging
- Labelling & Packaging Dispute
- Post-Marketing Surveillance
- Advertising
- Patent Protection & Intellectual Property Rights
- Pharmaceutical Pricing and Reimbursement
- Pricing Development
- Sales tax confusion
- Some medicine tariffs abolished
- Pharmacies
- Pharmacies by Province, 1998
- TRADE FAIRS
- Pakistan Pharma Expo
- DOMESTIC PRODUCTION
- Pharmaceutical Manufacturing Plants by Province, 2006
- Multinational Manufacturers, 2006
- Domestic Producers
- Abbott Laboratories (Pakistan) Ltd
- Sanofi-Aventis Ltd
- CCL
- Cyanamid (Pakistan) Ltd, Wyeth Lederle Division
- Efroze
- Epla Labs
- GlaxoSmithKline Pakistan Ltd
- Highnoon Laboratories Ltd
- Kobec Pharmacals
- Dr Raza Pharma Ltd
- Reckitt Benckiser Pakistan
- Searle Pakistan Ltd
- ZAFA Pharmaceutical Laboratories (Private) Ltd
- DIRECTORY
- Trade Associations
